Lonsec Investment Grade Rating

Lonsec Investment Grade Rating

HMC Capital High Conviction Alternatives Fund has been rated by Lonsec in August 2023. The Investment Grade rating was awarded to the fund.

For further details on the rating, please contact Chris Boyd at +61 416 077 166 or invest@hmccapital.com.au for a copy of the report if you are a licensed financial adviser.

 


Disclaimer

The rating issued 08/2023 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2023 Lonsec. All rights reserved.

Related

Sigma Healthcare's proposed merger with Chemist Warehouse Group gains ACCC approval
HMC Capital Partners Fund HMC Capital Partners Fund I Private Equity

Sigma Healthcare's proposed merger with Chemist Warehouse Group gains ACCC approval

HMC Capital - 1H FY24 Results
ASX Announcement HMC Capital High Conviction Alternatives Fund HMC Capital Partners Fund HMC Capital Partners Fund I

HMC Capital - 1H FY24 Results

HMCCP Fund 1 & HMCC HCAF - January 2024 Update
HMC Capital High Conviction Alternatives Fund HMC Capital Partners Fund HMC Capital Partners Fund I Private Equity

HMCCP Fund 1 & HMCC HCAF - January 2024 Update